Having confirmed that the 3D spheroid model recapitulates transcriptomic and protein characteristics of fibroblast foci, we proceeded to re-evaluate the potential of LOXL2 as a therapeutic target in lung fibrosis. Here, LOXL2 is linked to pulmonary fibrosis.